ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

トシル酸ブレチリウム

Bretylium Tosylate

HCID 6100
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
61-75-6
標準SMILES
CC[N+](C)(C)Cc1ccccc1Br.Cc1ccc(S(=O)(=O)[O-])cc1
InChIKey
KVWNWTZZBKCOPM-UHFFFAOYSA-M
分子式
C18H24BrNO3S
平均分子量
414.4 g/mol
単同位体質量
413.06603

概要

Bretylium tosylate is the tosylate salt of bretylium. It blocks noradrenaline release from the peripheral sympathetic nervous system, and is used in emergency medicine, cardiology, and other specialties for the acute management of ventricular tachycardia and ventricular fibrillation. It has a role as an antihypertensive agent, an adrenergic antagonist and an anti-arrhythmia drug. It is a quaternary ammonium salt and an organosulfonate salt. It contains a bretylium.

名称と識別子

優先名称
Bretylium Tosylate
IUPAC
(2-bromophenyl)methyl-ethyl-dimethylazanium;4-methylbenzenesulfonate
現地名
トシル酸ブレチリウム
英語名
BRETYLIUM TOSYLATE
分子式
C18H24BrNO3S
分子量
414.36

名称と別名

Bretylium tosylate61-75-6BretylolBretylium tosilateDarentinTosilato de bretilioTosilate de bretyliumBretylii tosilasASL-603(o-Bromobenzyl)ethyldimethylammonium p-toluenesulfonateBretilio tosilatoDTXSID1022685
名称をさらに表示
オルニドブレチリウム·p-トルエンスルホナートブレチロール2-ブロモ-N-エチル-N,N-ジメチルベンゼンメタンアミニウム·4-メチルベンゼンスルホナートブレチリウムp-トルエンスルホナートブレチリウムトシラートダレンチントシル酸ブレチリウムブレチリウム・p-トルエンスルホナート2-ブロモ-N-エチル-N,N-ジメチルベンゼンメタンアミニウム・4-メチルベンゼンスルホナートornidbretylanbretylatedarenthinesulfonicacidulfonicacid(1:1)BretyliuM p-Tolu
Bretylium Tosylate In Dextrose 5%NSC-621642-Bromo-N-ethyl-N,N-dimethylbenzenemethanaminium 4-methylbenzenesulfonateDimethylethyl-o-bromobenzylammonium-p-toluenesulphonateN-Ethyl-N-o-bromobenzyl-N,N-dimethylammonium tosylate78ZP3YR353Benzenemethanaminium, 2-bromo-N-ethyl-N,N-dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1)CHEBI:3173

物性

構造計算による物性

極性表面積
65.6 Ų
水素結合供与体数
0
水素結合受容体数
3
回転可能結合数
3
重原子数
24
形式電荷
0
複雑度
349

実験および物理化学的性質

Solubility>62.2 [ug/mL] (The mean of the results at pH 7.4)
Human Drugs · 2 件

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section140.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学的性質

融点
97 · 97-99°
貯蔵温度
Inert atmosphere,Room Temperature
溶解性
2 O: · H2O: 可溶性50mg/mL
外見
個体
色
白い
主な用途
医薬品(低分子化合物)
InChI
1S/C11H17BrN.C7H8O3S/c1-4-13(2,3)9-10-7-5-6-8-11(10)12;1-6-2-4-7(5-3-6)11(8,9)10/h5-8H,4,9H2,1-3H3;2-5H,1H3,(H,8,9,10)/q+1;/p-1
InChIKey
KVWNWTZZBKCOPM-UHFFFAOYSA-M
SMILES
Cc1ccc(cc1)S([O-])(=O)=O.CC[N+](C)(C)Cc2ccccc2Br

化学的性質

化学的特性White Solid

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P321, P330, P362+P364, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 41 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Other Safety InformationIMAP assessments - Benzenemethanaminium, 2-bromo-N-ethyl-N,N-dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1): Human health tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (100%)

安全データ

wgk
WGK 3
rtecs
BO9450000
毒性
LD50 in mice (mg/kg): 400 orally; 250 i.m. (Goldenthal)
hs_code
2923900100
risk_code
20/21/22
hazard_code
Xn
safety_code
36
Hazard Classifications
Acute Tox. 4 DermalAcute Tox. 4 InhalationAcute Tox. 4 Oral
ストレージクラス
11 - Combustible Solids

化学と産業

薬理情報

ATC Code · 2 件

C - Cardiovascular system

QC - Cardiovascular system

MeSH Pharmacological Classification · 3 件

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Drugs that bind to but do not activate ADRENERGIC RECEPTORS. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters EPINEPHRINE and NOREPINEPHRINE.

応用分野 · 2 件

使用Bretylium tosylate has a biphasic response, initially inducing norepinephrine release followed by sympathetic ganglionic blockade. Bretylium tosylate is a class III antiarrhythmic agent and a competitive inhibitor of acetylcholinesterase.

一般的な説明Bretylium tosylate, (o-bromobenzyl)ethyl dimethylammonium p-toluenesulfonate(Bretylol), is an extremely bitter, white, crystalline powder.The chemical is freely soluble in water and alcohol.Bretylium tosylate is an adrenergic neuronal-blockingagent that accumulates selectively in the neurons anddisplaces norepinephrine. Because of this property,bretylium was used initially, under the trade name ofDarenthin, as an antihypertensive agent. It caused posturaldecrease in arterial pressure. This use was discontinuedbecause of the rapid development of tolerance, erratic oralabsorption of the quaternary ammonium compound, andpersistent pain in the parotid gland on prolonged therapy.

上流・下流製品情報

関連反応

0 件
反応記録を作成
関連する反応はまだありません

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
61-75-6
PubChem CID
6100
DTXSID
DTXSID1022685
ChEMBL
CHEMBL1095292
ChEBI
CHEBI:3173
UNII
78ZP3YR353
EC Number
200-516-8

上流原料

o-トルイジンN,N-ジメチルベンジルアミン2-ブロモベンジルブロミド2-ブロモトルエンブロモメタンp-トルエンスルホン酸エチル
補足説明 · 1 件

定義ChEBI: The tosylate salt of bretylium. It blocks noradrenaline release from the peripheral sympathetic nervous system, and is used in emergency medicine, cardiology, and other specialties for the acute management of ventricular tachycardia and ventricular fibril ation.